Nebido 1000mg/4ml Solution For Injection
PACKAGE LEAFLET: INFORMATION FOR THE USER
Nebido®
1000 mg/4 ml solution for injection (testosterone undecanoate)
Your medicine is known by the above name, but will be referred to as Nebido throughout this leaflet.
Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
► Keep this leaflet. You may need to read it again.
► If you have any further questions, ask your doctor.
► This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
► If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Nebido is and what it is used for
2. What you need to know before you are given Nebido
3. How to use Nebido
4. Possible side effects
5. How to store Nebido
6. Contents of the pack and other information
1. What Nebido is and what it is used for
Nebido contains testosterone, a male hormone, as the active ingredient. Nebido is injected into a muscle in your body. There it can be stored and gradually released over a period of time. Nebido is used in adult men for testosterone replacement to treat various health problems caused by a lack of testosterone (male hypogonadism). These should be confirmed by two separate blood testosterone measurements and also include clinical symptoms such as:
► Impotence
► Infertility
► low sex drive
► tiredness
► depressive moods
► bone loss caused by low hormone levels
2. What you need to know before you are given Nebido
Do NOT use Nebido
► if you are allergic to testosterone undecanoate or any of the other ingredients of this medicine (listed in section
6)
► if you have androgen-dependent cancer or suspected cancer of the prostate or of the breast
► if you have had a liver tumour
______
The following information is intended for healthcare professionals only:
The solution for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used.
The contents of a vial are to be injected intramuscularly immediately after opening the vial.
The medicinal product is for single use only and any unused solution should be discarded.
Administration
Special care must be given to avoid intravasal injection.
As with all oily solutions, Nebido must be injected strictly intramuscularly and very slowly. Pulmonary microembolism of oily solutions can in rare cases
Nebido is not intended for use in women.
Nebido is not for use in children and adolescents. There is no data available on the use of Nebido in males under 18 years of age.
Warnings and precautions
Talk to your doctor before using Nebido if you have or
have ever had:
► epilepsy
► heart, kidney or liver problems
► migraine
► temporary interruptions in your breathing during sleep (apnoea), as these may get worse
► cancer, as the level of calcium in your blood may need to be tested regularly
► blood clotting problems
► high blood pressure or if you are treated for high blood pressure, as testosterone may cause a rise in blood pressure.
If you are suffering from severe heart, liver or kidney disease, treatment with Nebido may cause severe complications in the form of water retention in your body sometimes accompanied by (congestive) heart failure.
The following blood checks should be carried out by your doctor before and during the treatment: testoterone blood level, full blood count.
If your liver is not working No formal studies have been performed in patients with liver impairment. You will not be prescribed Nebido if you have ever had a liver tumour (see 'Do not use Nebido’). Elderly patients (65 years or older)
There is no need for your doctor to adjust the dose if you are over 65 (see "Medical examination/follow up").
Muscle building and drug tests
Nebido is not suitable for building muscles in healthy
individuals or for increasing physical strength.
Nebido might lead to positive results in drug tests.
Medical examination/Follow-up Male hormones may increase the growth of prostate cancer and enlarged prostate glands (benign prostatic hypertrophy). Before your doctor injects Nebido, he/she will examine you to check that you do not have prostate cancer. Your doctor will regularly examine your prostate and breast, especially if you are elderly. He/she will also take regular blood samples.
Following the use of hormonal substances such as androgen compounds, cases of benign (non-cancerous) and malignant (cancerous) liver tumours have been observed to occur.
Other medicines and Nebido
Tell your doctor or pharmacist if you are using or have
recently used or might use any other medicines, including
lead to signs and symptoms such as cough, dyspnoea, malaise, hyperhidrosis, chest pain, dizziness, paraesthesia, or syncope. These reactions may occur during or immediately after the injection and are reversible. Treatment is usually supportive, e.g. by administration of supplemental oxygen. Suspected anaphylactic reactions after Nebido injection have been reported.
Warnings
Careful and regular monitoring of the prostate gland and breast must be performed in accordance with recommended methods (digital rectal examination and estimation of serum PSA) in patients receiving testosterone therapy at least once yearly and twice yearly in elderly patients and at risk patients (those with clinical or familial factors).
medicines obtained without a prescription. The doctor may need to adjust the dose if you are using any of the following:
► the hormone ACTH or corticosteroids (used to treat various conditions such as rheumatism, arthritis, allergic conditions and asthma): Nebido may increase the risk of water retention, especially if your heart and liver are not working properly
► blood-thinning tablets (coumarin derived oral anticoagulants) since this can increase the risk of bleeding. Your doctor will check the dose.
► medicines used to treat diabetes. It may be necessary to adjust the dose of your blood sugar reducing medicine. Like other androgens, testosterone may increase the effect of insulin.
Please be sure to inform your doctor if you suffer from a disturbance of blood clotting, because this is important for your doctor to know before deciding to inject Nebido.
Nebido may also affect the results of some laboratory tests (e.g. thyroid gland). Tell your doctor or the laboratory staff that you are using Nebido.
Pregnancy and breast-feeding
Nebido is not for use in women and must not be used in
pregnant or breast-feeding women.
Fertility
Treatment with high doses of testosterone preparations commonly may reversibly stop or reduce sperm production (see also under "Possible side effects").
Driving and using machines
Nebido has no observed effect on your ability to drive or use
machines.
3. How to use Nebido
Your doctor will inject Nebido (1 vial) very slowly into a muscle. He/she will give you the injections every 10 to 14 weeks. This is enough to maintain sufficient testosterone levels without leading to a build-up of testosterone in the blood.
Nebido is strictly for intramuscular injection. Special care will be taken to avoid injection into a blood vessel.
Start of treatment
Your doctor will measure your blood testosterone levels before starting treatment and during the early stages of treatment. Your doctor may give you the second injection after only six weeks in order to quickly reach the necessary testosterone level. This will depend on your symptoms and testosterone levels.
Maintaining your Nebido levels during treatment
The injection interval should always be within the recommended range of 10 to 14 weeks.
Your doctor will measure your testosterone levels regularly at the end of an injection interval to make sure it is at the right level. If the level is too low, your doctor may decide to give you injections more often. If your testosterone levels are high, your doctor may decide to give you injections less often. Do not miss your injection appointments. Otherwise, your optimum level of testosterone will not be maintained.
If you think that the effect of Nebido is too strong or too weak, talk to your doctor.
______ _>^_
Besides laboratory tests of the testosterone concentrations in patients on long-term androgen therapy the following laboratory parameters should be checked periodically: haemoglobin, haematocrit, and liver function tests and lipid profile.
In patients suffering from severe cardiac, hepatic or renal insufficiency or ischaemic heart disease, treatment with testosterone may cause severe complications characterised by oedema with or without congestive cardiac failure. In such case, treatment must be stopped immediately.
POM
Ifyouusemore Nebidotl^i^iijrou uld
Sym ptoms of having too much Nebido include:
► irribatjility
► nervouoness
► woiohtgaio
► h)nc^^iastir^n(^rf^^t]unntusyctione bellynuoidostau if yonhavecnyoCtheae. Your doffmlll isjentiUleosoftenunwill stop treatment.
4. Sbosot blesideeffeoSe
c|lco ub| mocbcineS1 RsmecHdnesonoouse side effecs^
aiChvuithaaS vearo^i,or|0 ^tstliufm
Thh mothe yommon a:olih bffhuaoarhaoeaa nd p ahro^ftcu/
^ehi:l/aheisaiaaiaen.
(ommonoido e0fegOs|mcycffoctuets1ie 10 pet ients):
► abnormally high levels of red blood cells
► waigit ohio
► UoI fiasOus
► ame
► csbrgocl prosro0ea(O osgtciatedtroblems
► various reactions where the injection was given (e.s: train, broIsiug ^1^11011)
Uoiaommon sMo effenau itsyn a0i|osh i^)rt^o 1 in R Oatieyth)i
lh^Ne((reh^tlon
|ib inert sasl cppebhe.chanyhsisl;lood test res^^^^ (s.g. iotius^^d ti^wlsuftooe or fats)
► depression, emotional disorder, insomnia, rennin ssneh rggrorrioo, or irritability
► heaaacea,migiolnesOrttem ut
► sfu^iootsoai aieStso^i^Orih^lf Oir^oas^rh^ure, nr dizziness
► bronchitis, sinusihis, cwir^li,etutite ss of breaR scoriuOlOrtoIce yroblems
► tharriioea^rnaaose
► chandesm|iocutcsrrcso(c
► oho Sth, dt otoi (ttoo skis ta uiS. on f r(.r|. itchin. oellS^s:ing,l^lOraoCit^S
► joint pain, pain in limbs, muscle problems (e.R phrm, l^i^br(^rstiffr^ess),orarin creased creatine
p hosphokinase in the blood
► sipb ary tract disorders (e.g. decreased flow of urine, usib ary retention, urge to pass urine at night)
► ouos0atio dbordoss .syt. .rosSaOio intoaepithelial gooe|hi>ig, or Sidadhirina oi inoommaNon of tha tooseat:e)l drangM lo sgooa|onoec|tg)painful testicles, [reisOah Oardtood or oniosged oreasts, or increased itveio tOoas|eooafcm akhormone s
► tiredness, general feeling of weakness, excessive sweating, or night sweats
0^rare^ideeOn^^oPsrprb(ovntbcr u|to 1 in 1000 patients):
► TaroiiybguieNnbido mayroachtheiu ngs (pulmonary microembolism of oily solutions) which can in rare cases laad ft gi(osacdsympromssachgssoug h, shortness of breath, feeling generally unwell, excessive sweating, cesstpaio,Oizzineos,"pinaeodnde dies", or fainting. Ohane reactions may occur during or immediately after Chg|njecS|on and are reversible.
Suspected anaphylactic reactions after Nebido injection have been reported.
In addition to the side effects listed above the following lave been reported following treatment with preparations containing testosterone: nervousness, hostility, brief interruptions in breathing during sleep, various skin reactions including dandruff and oily skin, increased hair srowth, more frequent erections, and very rare cases of yellowing of the skin and eyes (jaundice).
Treatment with high doses of testosterone preparations uommosly senior ceducesapermprodu ction, although this retusornohormalaftpr tseetmcn t ceases. Testosterone foploham^nt thofappooahorly finc0ion ing testicles (ty^onacbsm) carm rare cgsusrcuse persistent, painful erections (priapism). High-dosed or long-term rOministrationof tesporossopb eccusio nally increases the orcutrencesprwafer roUeoCioponOor dema (swelling due to fluid retention).
rortnstnstproneproOutUs!n gsnpral n cummon risk of isooencedredniopd cpllosuntrbaemntoc rit (percentage of sod nines cells, ell ood)snd hpemrrglebin (the component misoo nieencellsthat sasrieeoupoen), were observed by drsiooic niepp f^t^r. rSeoorSin(for:s(de efUMts
Ifnr^irr^ernnpri^o ntg^otm teld toysrrr doctor or pharmacist. TIHsincludes enb pngsRo sMoeffyslo not listed in this lerfiot.ce)ucfea|sp reirortnideeffruSscbrectly via the YellowCardSchemnat:w ww.mhra.gov.uk/yellowcard. lire nsrSinerideeffepCrooapcnhblpp rovide more information on the safety of this medicine.
5^000^0^006 oUsebido
Keep out of the sight and reach of children.
This meciicie alproSsct doesnstre quire any special storage conditions.
yoooCsss eenso efterOOeoPbiry bode which is stated on the carton and the label after "EXP". The expiry date refers tothgiysCOeyeSteorm enth.
Medicines should not be disposed of via wastewater or beocsnold mosSe.deUoourenarmacist how to dispose of modicmesnolongosuoquired.T hese measures will help to protect the environment.
6. Contents of the pack and other information
What Nebido contains
Each ml of solution contains 250 mg testosterone undecanoate equivalent to 157.9 mg testosterone.
Each vial with 4 ml solution for injection contains 1000 mg testosterone undecanoate.
The other ingredients are benzyl benzoate and refined castor oil.
What Nebido looks like and contents of the pack
A brown glass vial with a grey bromobutyl (foil clad ETFE) injection stopper and brown bordered cap containing a clear yellowish oily solution.
1 x 4ml vial
Who manufactured your medicine
Manufactured by Bayer Pharma AG, D-13342 Berlin, Germany.
Procured from within the EU and repackaged by Product Licence Holder Ennogen Healthcare Ltd., Unit G4 Riverside Industrial Estate, Riverside Way, Dartford, Kent DA1 5BS.
PL 40739/0048
Leaflet date: 31.08.2016 Ref: NebI/v2
Nebido is a registered trademark of Bayer Intellectual Property GmbH.
&
Notes on hand lingihovial
The vial is for sindie uon onig,Tho«lnSiogofa dial ig0ube injected intramuccuiaric immeUiofulnaUterdrawinouv into the syringe. hftdlsomovaioOSheclaoticchpiO) Oo not remove the metal ring(B)orthocrimp ampin).